Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365))

Stefan H Faderl; A. Ferrajoli; W. Wierda; Susan O'Brien; S. Lerner; M. J. Keating

doi:10.1002/cncr.25434

Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365))

Stefan H Faderl
, A. Ferrajoli
, W. Wierda
, Susan O'Brien
, S. Lerner
, M. J. Keating

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	3982
Number of pages	1
Journal	Cancer
Volume	116
Issue number	16
DOIs	https://doi.org/10.1002/cncr.25434
State	Published - Aug 15 2010

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.25434

Cite this

Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365)). / Faderl, Stefan H; Ferrajoli, A.; Wierda, W. et al.
In: Cancer, Vol. 116, No. 16, 15.08.2010, p. 3982.

Research output: Contribution to journal › Comment/debate › peer-review

@article{7888b679d2404e58bfb12498ae28a0af,

title = "Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365))",

author = "Faderl, \{Stefan H\} and A. Ferrajoli and W. Wierda and Susan O'Brien and S. Lerner and Keating, \{M. J.\}",

year = "2010",

month = aug,

day = "15",

doi = "10.1002/cncr.25434",

language = "English (US)",

volume = "116",

pages = "3982",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "16",

}

TY - JOUR

T1 - Erratum

T2 - Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365))

AU - Faderl, Stefan H

AU - Ferrajoli, A.

AU - Wierda, W.

AU - O'Brien, Susan

AU - Lerner, S.

AU - Keating, M. J.

PY - 2010/8/15

Y1 - 2010/8/15

UR - https://www.scopus.com/pages/publications/77956811402

UR - https://www.scopus.com/pages/publications/77956811402#tab=citedBy

U2 - 10.1002/cncr.25434

DO - 10.1002/cncr.25434

M3 - Comment/debate

AN - SCOPUS:77956811402

SN - 0008-543X

VL - 116

SP - 3982

JO - Cancer

JF - Cancer

IS - 16

ER -

Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence (Cancer (2010), 116, (2360-2365))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this